Key Clinical Message:
Owing to autoantibody production and thrombophilic disorders in
COVID-19, physicians must have low threshold to investigate secondary
IIH and demyelinating disorders in patients with headache and decreased
vision following recent COVID-19 infection.
Keywords: Coronavirus; SARS-CoV-2; COVID-19; Neurological
manifestations; NMOSD; Anti-MOG syndrome; Pseudotumor cerebri.